Multidisciplinary Symposium on the Immunological Consequences of Targeted Immune Therapies
Secondary immunodeficiencies become more and more common and widespread as they develop in the course of numerous diseases and result from a variety of therapeutic conditions. ESID 2021 is a unique multidisciplinary symposium bringing together professionals from different fields to share their expertise in the treatment and management of acquired immunodeficiencies.
Submit your research before 1 June 2021 and make an impact. Progress is in your hands.
For more information, please visit the Symposium website – https://2021.esidmeeting.org/